-
Views
-
Cite
Cite
Elias J. Anaissie, Ray Hachem, Catherine Legrand, Philippe Legenne, Paul Nelson, Gerald P. Bodey, Lack of Activity of Amphotericin B in Systemic Murine Fusarial Infection, The Journal of Infectious Diseases, Volume 165, Issue 6, June 1992, Pages 1158–1160, https://doi.org/10.1093/infdis/165.6.1155
- Share Icon Share
Abstract
Systemic fusarial infections have emerged as a significant cause of mortality in cancer patients. Yet, little is known about the management of these infections. The in vivo antifungal activity of amphotericin B in CF1 mice with disseminated fusarial infections was studied. Two pathogenic strains of Fusarium solani were used. Intraperitoneal administration of amphotericin B in daily doses of 0.5, 1, and 2 mg/kg for ⩽10 days did not prolong survival oftreated animals. Clearance of F. solani from kidneys was similar in mice treated with 1 mg/kg per day of amphotericin Band in untreated animals. These results are in agreement with the known in vitro and in vivo resistance of Fusarium species to amphotericin B.